Quantity size:
0.2ml
Concentration:
1mg/ml DAP凋亡诱导蛋白激酶2抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase related apoptosis inducing protein kinases).DAP凋亡诱导蛋白激酶2抗体 DRAKs contain an N terminal kinase domain and a C terminal regulation domain. Overexpression of DRAK2 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues.
DAP凋亡诱导蛋白激酶2抗体Also known as:
DAP kinase related apoptosis inducing protein; DAP kinase related apoptosis inducing protein kinase 2; Death associated protein kinase related 2; DRAK 2; Serine/threonine kinase 17b (apoptosis inducing); Serine/threonine kinase 17b; Serine/threonine protein kinase 17B;DAP凋亡诱导蛋白激酶2抗体 STK17B; ST17B_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human DRAK2.
●
DAP凋亡诱导蛋白激酶2抗体Predicted Molecular Weight: 42kDakDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl395Hu01羧肽酶A3(CPA3)多克隆抗体Polyclonal Antibody to Carboxypeptidase A3, Mast Cell (CPA3)
kl395Mu01羧肽酶A3(CPA3)多克隆抗体Polyclonal Antibody to Carboxypeptidase A3, Mast Cell (CPA3)
kl395Ra01羧肽酶A3(CPA3)多克隆抗体Polyclonal Antibody to Carboxypeptidase A3, Mast Cell (CPA3)
kl397Hu01羧肽酶M(CPM)多克隆抗体Polyclonal Antibody to Carboxypeptidase M (CPM)
kl400Mu01肉毒碱乙酰转移酶(CRAT)多克隆抗体Polyclonal Antibody to Carnitine Acetyltransferase (CRAT)
kl401Hu01促肾上腺皮质素释放激素结合蛋白(CRHBP)多克隆抗体Polyclonal Antibody to Corticotropin Releasing Hormone Binding Protein (CRHBP)
kl401Ra01促肾上腺皮质素释放激素结合蛋白(CRHBP)多克隆抗体Polyclonal Antibody to Corticotropin Releasing Hormone Binding Protein (CRHBP)
kl402Hu01半胱氨酸丰富蛋白1(CRIP1)多克隆抗体Polyclonal Antibody to Cysteine Rich Protein 1, Intestinal (CRIP1)
kl407Hu01隐花色素1(CRY1)多克隆抗体Polyclonal Antibody to Cryptochrome 1 (CRY1)
kl410Hu01组织蛋白酶E(CTSE)多克隆抗体Polyclonal Antibody to Cathepsin E (CTSE)
kl411Hu01肘臀蛋白(CUBN)多克隆抗体Polyclonal Antibody to Cubilin (CUBN)
kl416Mu01钙蛋白酶抑制蛋白(CAST)多克隆抗体Polyclonal Antibody to Calkltatin (CAST)
kl417Hu01肉毒碱棕榈酰基转移酶2(CPT2)多克隆抗体Polyclonal Antibody to Carnitine klmitoyltransferase 2, Mitochondrial (CPT2)
kl417Ra01肉毒碱棕榈酰基转移酶2(CPT2)多克隆抗体Polyclonal Antibody to Carnitine klmitoyltransferase 2, Mitochondrial (CPT2)
kl418Hu01过氧化氢酶(CAT)多克隆抗体Polyclonal Antibody to Catalase (CAT)
kl418Mu01过氧化氢酶(CAT)多克隆抗体Polyclonal Antibody to Catalase (CAT)
kl418Ra01过氧化氢酶(CAT)多克隆抗体Polyclonal Antibody to Catalase (CAT)
kl419Hu0118kDa阳离子抗菌肽(CAMP)多克隆抗体Polyclonal Antibody to Cathelicidin Antimicrobial Peptide (CAMP)
kl423Hu01圆柱瘤蛋白(CYLD)多克隆抗体Polyclonal Antibody to Cylindromatosis (CYLD)
kl424Hu01半胱氨酰白三烯受体1(CYSLTR1)多克隆抗体Polyclonal Antibody to Cysteinyl Leukotriene Receptor 1 (CYSLTR1)
kl425Hu01囊性纤维化跨膜传导调节因子(CFTR)多克隆抗体Polyclonal Antibody to Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
kl426Hu01细胞球蛋白(CYGB)多克隆抗体Polyclonal Antibody to Cytoglobin (CYGB)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话